Manifestaciones neurológicas asociadas a la vacuna contra COVID-19

Manifestaciones neurológicas asociadas a la vacuna contra COVID-19

Resumen: Introducción: La enfermedad por coronavirus 2019 (COVID-19) se ha propagado de forma rápida, dando lugar a una situación de pandemia, con importante morbimortalidad. En este contexto han surgido un amplio número de vacunas para tratar de hacer frente a la enfermedad. Objetivo: Revisar los...

Full description

Saved in:

Bibliographic Details
Main Authors:	R. Alonso Castillo, J.C. Martínez Castrillo
Format:	Article
Language:	Spanish
Published:	Elsevier España 2025-01-01
Series:	Neurología
Subjects:	COVID-19 vaccines SARS-CoV-2 vaccines Adverse event Neurological manifestations Neurological pathology Safety
Online Access:	http://www.sciencedirect.com/science/article/pii/S0213485322001876
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

SARS-CoV-2 associated encephalitis
by: Jasmina Poluga, et al.
Published: (2025-05-01)

Mpox Virus Infection and Vaccination: Immunopathogenesis and Exploring the Link to Neuropsychiatric Manifestations
by: Helal F. Hetta, et al.
Published: (2024-12-01)

Pathophysiology and Clinical Characteristics of Neuropathies in COVID-19 Patients: A Narrative Review
by: Calle-Meneses, Andrés, et al.
Published: (2025-04-01)

Impact, Trends, and Visibility of Scientific Publications on Neurological Effects of COVID-19 Vaccine: A Scientometric Analysis
by: Ana Paula Sangama Ramírez, et al.
Published: (2025-04-01)

COVID-19: A brain virus? COVID-19 and neurological manifestations: a systematic review
by: Muhammad Mohsin Khan, et al.
Published: (2025-06-01)

Peripheral Nervous System Complications after COVID-19 Vaccination
by: Seyed Sepehr Khatami, et al.
Published: (2025-03-01)

Manifestações neurológicas de dengue: estudo de 41 casos Neurological manifestations of dengue: study of 41 cases
by: Maria Lúcia Brito Ferreira, et al.
Published: (2005-06-01)

Safety Assessment of Inactivated Whole Virion Booster Vaccine against the SARS-CoV-2 Virus (BelCovidVac) in Immunized Study Subjects aged 18 to 60 Years (day 28)
by: I. O. Stoma, et al.
Published: (2024-07-01)

SARS-CoV-2 Trasmission and Outcome in Neuro-rehabilitation patients hospitalized at Neuroscience Hospital in Italy
by: Francesco Di Gennaro
Published: (2020-08-01)

Neurological manifestations of intussusceptions in a group of patients aged below 5 years
by: Jasim Mohammed hashim
Published: (2012-04-01)

Reported Adverse Events Following SARS-CoV-2 Vaccinations in the Canadian Province of Alberta and Associated Risk Factors: A Retrospective Cohort Study
by: Yei Mansou, et al.
Published: (2024-12-01)

Severe immune thrombocytopenia (ITP) following SARS-CoV-2 mRNA vaccine in a girl on immunosuppressive treatment and in prolonged stable phase of ITP.
by: SIMONA BIANCHI, et al.
Published: (2022-01-01)

Features of the course of influenza in some categories of neurological patients
by: E. G. Demianovskaya, et al.
Published: (2021-07-01)

Adverse reactions following first three doses of the BNT162b2 mRNA COVID-19 vaccine: A prospective cohort study on relationships with individual characteristics and previous experience of adverse reactions
by: Ayako Konishi, et al.
Published: (2025-12-01)

DARE-SAFE: Denominator-Adjusted Rate Estimates of Substance Adverse Events Frequency Evaluation in Pharmaceuticals and Vaccines
by: Matthew Halma, et al.
Published: (2025-03-01)

Comparative safety evaluation of intranasal and intramuscular immunisation with Ad26 and Ad5-vectored vaccines to prevent coronavirus infection
by: E. V. Zuev, et al.
Published: (2023-10-01)

Eritema fijo asociado a la vacuna contra el SARS-CoV-2
by: Daiana M. Cisnero, et al.
Published: (2025-01-01)

Prediction, prevention, and precision treatment of immune checkpoint inhibitor neurological toxicity using autoantibodies, cytokines, and microbiota
by: Alberto Vogrig, et al.
Published: (2025-03-01)

Role of retroelements in the development of COVID-19 neurological consequences
by: Rustam N. Mustafin, et al.
Published: (2022-09-01)

Adverse Events Associated With SARS-CoV-2 Vaccination in Patients With Glomerular Diseases and the Potential Risk of Disease Reactivation
by: Sophia Lionaki, et al.
Published: (2024-11-01)

Clinical characteristics of 30 children with severe acute SARS‐CoV‐2 infection
by: Weijun Li, et al.
Published: (2024-12-01)

Acute cerebral edema: a lethal neurological complication in a patient with COVID-19 infection. Case report and literature review
by: M. Puodžiūnaitė, et al.
Published: (2023-10-01)

PROFILE OF NEUROLOGICAL MANIFESTATIONS IN PRIMARY SJOGREN’S SYNDROME
by: M S Panchovska, et al.
Published: (2002-06-01)

A case of brainstem encephalitis with acute neuropathy associated with prolonged chikungunya viraemia
by: Tembe Carveth-Johnson, et al.
Published: (2025-01-01)

Prevalence of Neurological Symptoms in Patients with COVID-19 Hospitalized in Hospitals of Arak University of Medical Sciences
by: Alireza Rezaie Ashtiani, et al.
Published: (2024-10-01)

Manifestaciones neurológicas asociadas a vacunación
by: Laura Lacruz-Ballester, et al.
Published: (2024-07-01)

Impact of prior COVID-19 vaccination on major adverse kidney events in patients with non-dialysis dependent chronic kidney disease: a global retrospective study
by: Chi-Ya Huang, et al.
Published: (2025-12-01)

Post-marketing safety surveillance of pneumococcal vaccines: a real-world pharmacovigilance study using the U.S. vaccine adverse event reporting system (VAERS) database
by: Xinkuo Zheng, et al.
Published: (2025-08-01)

Influence of previous COVID-19 exposure and vaccine type (CoronaVac, ChAdOx1 nCov-19 or BNT162b2) on antibody and cytokine (Th1 or Th2) responses
by: Diana Lourdes Padilla-Bórquez, et al.
Published: (2024-12-01)

Longitudinal Characterization of SARS-CoV-2 Immunity in Hemodialysis Patients Post Omicron
by: Andrew H. Karaba, et al.
Published: (2025-02-01)

Prospective Follow-Up of Neurological Findings and Recovery Tımes in COVID-19 Patients
by: Mirkan Bulğak, et al.
Published: (2025-02-01)

Pharmacological management of seizures in patients with COVID-19: a systematic review [version 2; peer review: 2 approved]
by: Priscilla Kolibea Mante, et al.
Published: (2021-11-01)

Adverse event reporting following immunization of hepatitis B vaccine: A 13-year review
by: Xiaoying Gong, et al.
Published: (2024-12-01)

COVID-19 vaccination: challenges in the pediatric population
by: Alice Nicoleta Azoicai, et al.
Published: (2025-01-01)

Safety and Immunogenicity of the Tetravalent Recombinant COVID-19 Protein Vaccine SCTV01E in Children and Adolescents Aged 3 to 17 Years: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial
by: Fengcai Zhu, et al.
Published: (2025-01-01)

Immunogenicity of monovalent and multivalent subunit vaccines against SARS-CoV-2 variants in mice with divergent vaccination history
by: Rui Wang, et al.
Published: (2025-08-01)

Seizures Following DTP Immunization
by: J Gordon Millichap
Published: (1988-03-01)

Neurological adverse events associated with antidepressants: a comprehensive 22-year analysis of the FDA adverse event reporting system
by: Qian Yu, et al.
Published: (2025-08-01)

Neurological Adverse Events Associated with the Use of Janus Kinase Inhibitors: A Pharmacovigilance Study Based on Vigibase
by: Sunny Park, et al.
Published: (2025-03-01)

Neurological manifestations of systemic rheumatic diseases. Possibilities of pharmacological
by: T A Raskina, et al.
Published: (2011-12-01)